Efficacy and safety of sofosbuvir-based therapies in patients with advanced liver disease in a real-life cohort

BACKGROUND: The combination of sofosbuvir (SOF) with ribavirin (RBV) or daclatasvir (DCV) or simeprevir (SIM) for the treatment of patients infected by chronic hepatitis C (CHC) have led to significantly increased rates of sustained virological response (SVR). However, there is only limited data reg...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hepat Med
Autors principals: Kutala, Blaise K, Mouri, Feryel, Castelnau, Corinne, Bouton, Valerie, Giuily, Nathalie, Boyer, Nathalie, Asselah, Tarik, Marcellin, Patrick
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5739107/
https://ncbi.nlm.nih.gov/pubmed/29296102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/HMER.S149578
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars